Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ALK’s pivotal phase 3 trial in children published in reputable scientific journal
-
Bayport Management Ltd receives consent from requisite majorities of bondholders for the exchange of its outstanding senior and subordinated social bonds
-
Fujifilm to Debut Several New Leading-Edge Medical Innovations at the RSNA 2024 Conference
-
Fujifilm to Highlight the Speed of Synapse VX for Mammography and Cardiology, Cloud-Native Architecture and AI-Driven Workflows at RSNA 2024
-
Albion Development VCT PLC: Interim Management Statement
-
Y-mAbs to Participate at Citi’s 2024 Global Healthcare Conference
-
The UN Climate Change Conference (COP29) concluded successfully in Azerbaijan
-
StoneX Financial Achieves GCM Status with ECC
-
FlexShopper Announces Record Date for Proposed Rights Offering
-
Symbotic shares tumble 24% as company files to delay 10-k annual report
-
Red Pine Prospecting Confirms Significant Gold Mineralization at the War Eagle Zone, Wawa Gold Project
-
Kronos Bio Announces CEO Transition and Reduction in Force
-
Prelude Therapeutics to Participate in Citizens JMP Securities Hematology and Oncology Summit
-
LeddarTech Announces Presence at CES 2025, Las Vegas: Demonstrating Their Latest AI-Driven Automotive Software in Collaboration with Arm and Texas Instruments
-
Company announcement no 20/2024 October 2024 Sales price
-
IDEX Biometrics ASA: Mandatory notification of trade by primary insider – 27 Nov 2024
-
Ocugen CEO to Present at NobleCon20 – Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference
-
Mavenir’s Network Intelligence as a Service (NIaaS) Wins the Advancing Artificial Intelligence Award at the 2024 Glotels
-
Lithium Ionic Secures LOI from EXIM for US$266M, Representing 100% of Bandeira Project CAPEX
-
CMG Announces Appointment of Herman Nieuwoudt as President, Bluware
-
NurExone Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
Arvinas to Present at Piper Sandler 36th Annual Healthcare Conference
-
Troilus Provides Update on its 2024 Annual General Meeting Materials amid Canada Post Strike
-
Abcourt Intersects 57.5 g/t over 0.6 m at the Sleeping Giant Mine
-
First Helium Confirms Plans for Sequential Drilling of Two Oil Targets - Proven Undeveloped (“PUD”) Oil Location and Large Leduc Anomaly
-
Metro is helping Ontario’s “Merrymakers” spread Holiday Joy by extending their impact
-
ZEREBRO, a Meme Coin, Will Be Listed on CoinW Exchange
-
Updated MDNA11 Monotherapy and Combination Clinical Data from the Ongoing Phase 1/2 ABILITY-1 Study to be Presented at the 2024 Immunotherapy Bridge Conference
-
Krystal Biotech to Present at Upcoming Investor Conferences
-
WW International, Inc. Announces CFO Transition
-
CervoMed Announces Orphan Drug Designation Granted to Neflamapimod by U.S. Food and Drug Administration for the Treatment of Frontotemporal Dementia
-
Beamr Joins AWS Marketplace, Expanding Access to its Global Customer Base
-
TransCode Therapeutics, Inc. Announces $8 Million Private Placement
-
Symbotic Provides Update to Restatement of Fiscal Year 2024 Financial Results and First Quarter of Fiscal Year 2025 Outlook
-
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology
-
Perspective Therapeutics to Participate in Upcoming Investor Conferences in December
-
Green Thumb Industries Repaid on Cansortium Loan
-
Enthusiast Gaming Announces Transition of Chief Financial Officer
-
AmpAura, a New Entrant, Disrupts with High-End $1800 Home Backup Power Solution
-
Supporting and Empowering Nursing Moms: Momcozy’s Thanksgiving ‘Nurse Comfortably, at No Cost’ Campaign Concludes
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
-
Codere Online Reports Financial Results for the Third Quarter 2024
-
EDAP to Participate in the Piper Sandler 36th Annual Healthcare Conference
-
Children Believe calls on Canadians to help #DisruptHunger this Giving Tuesday
-
YieldMax™ ETFs Announces Distributions on YBIT (115.71%), TSLY (103.42%), SNOY (101.96%), YMAX (87.35%), YMAG (54.24%) and Others
-
BOS Reports Financial Results for the Third Quarter of the Year 2024
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
Outlook Therapeutics® Announces Preliminary Topline Results of NORSE EIGHT Clinical Trial
-
Form 8.3 - [ECKOH PLC - 26 11 2024] - (CGWL)
-
Goodfood Reports Fiscal Year and Fourth Quarter 2024 Results with Net sales of $153 million and $34 million, Gross Profit of $63 million and $13 million and Adjusted EBITDA¹ of $9 million and $0.5 mi

